Literature DB >> 15639478

Transmural dispersion of repolarization as a key factor of arrhythmogenicity in a novel intact heart model of LQT3.

Peter Milberg1, Nico Reinsch, Kristina Wasmer, Gerold Mönnig, Jörg Stypmann, Nani Osada, Günter Breithardt, Wilhelm Haverkamp, Lars Eckardt.   

Abstract

BACKGROUND: Congenital and acquired long QT syndrome (LQTS) are caused by abnormalities of ionic currents underlying ventricular repolarization. For a better understanding of the mechanisms by which functional electrical instability at the level of the whole heart leads to torsade de pointes (TdP), a novel model of LQT3 was developed and the role of transmural dispersion of repolarization for the development of proarrhythmia was evaluated. METHODS AND
RESULTS: In 11 Langendorff-perfused rabbit hearts, veratridine (0.1-0.5 microM), an inhibitor of sodium channel inactivation, led to a concentration-dependent increase in QT-interval and simultaneously recorded monophasic ventricular action potentials (MAPs) (p<0.05) and thereby mimicked LQT3. Veratridine reproducibly induced early afterdepolarizations (EADs) and TdP after lowering potassium concentration. In bradycardic (AV-blocked) hearts, the increase in MAP duration showed marked regional differences. It was significantly more pronounced on the left endocardium as compared to left or right epicardium. This resulted in a significant increase in dispersion of repolarization (24% at 0.1 microM, 92% at 0.25 microM, 208% at 0.5 microM; p<0.01). Left ventricular transmural dispersion of repolarization increased significantly more than interventricular dispersion (104 to 33 ms at 0.5 microM veratridine; p<0.05).
CONCLUSION: By inhibition of sodium channel inactivation, veratridine mimics LQT3 in this intact heart model. In bradycardic, hypokalemic hearts, it reproducibly induced EADs and TdP in the setting of significantly increased left ventricular transmural dispersion of repolarization. Based on these experimental data, reduction of transmural dispersion of repolarization may be considered an important target for the prevention of TdP in patients with LQT3.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15639478     DOI: 10.1016/j.cardiores.2004.10.016

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  28 in total

Review 1.  The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis.

Authors:  Charles Antzelevitch; Luiz Belardinelli
Journal:  J Cardiovasc Electrophysiol       Date:  2006-05

2.  Blockade of I(Ca) suppresses early afterdepolarizations and reduces transmural dispersion of repolarization in a whole heart model of chronic heart failure.

Authors:  P Milberg; M Fink; C Pott; G Frommeyer; J Biertz; N Osada; J Stypmann; G Mönnig; M Koopmann; G Breithardt; L Eckardt
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

3.  Assessment of total cardiac repolarization's spatial distribution among patients with aortic sclerosis.

Authors:  Oguzhan Ekrem Turan; Mustafa Ozturk; Abdulselam Ilter; Mustafa Inc; Kayihan Karaman; Gulhanim Kiris; Merih Kutlu
Journal:  Int J Clin Exp Med       Date:  2015-03-15

4.  Tpeak-Tend and Tpeak-Tend dispersion as risk factors for ventricular tachycardia/ventricular fibrillation in patients with the Brugada syndrome.

Authors:  Jesus Castro Hevia; Charles Antzelevitch; Francisco Tornés Bárzaga; Margarita Dorantes Sánchez; Francisco Dorticós Balea; Roberto Zayas Molina; Miguel A Quiñones Pérez; Yanela Fayad Rodríguez
Journal:  J Am Coll Cardiol       Date:  2006-04-17       Impact factor: 24.094

Review 5.  Brugada syndrome.

Authors:  Charles Antzelevitch
Journal:  Pacing Clin Electrophysiol       Date:  2006-10       Impact factor: 1.976

Review 6.  Triple threat: the Na+/Ca2+ exchanger in the pathophysiology of cardiac arrhythmia, ischemia and heart failure.

Authors:  Christian Pott; Lars Eckardt; Joshua I Goldhaber
Journal:  Curr Drug Targets       Date:  2011-05       Impact factor: 3.465

7.  Criteria for arrhythmogenicity in genetically-modified Langendorff-perfused murine hearts modelling the congenital long QT syndrome type 3 and the Brugada syndrome.

Authors:  Ian N Sabir; Lucia M Li; Victoria J Jones; Catharine A Goddard; Andrew A Grace; Christopher L-H Huang
Journal:  Pflugers Arch       Date:  2007-09-06       Impact factor: 3.657

8.  Potentiation of E-4031-induced torsade de pointes by HMR1556 or ATX-II is not predicted by action potential short-term variability or triangulation.

Authors:  G Michael; J Dempster; K A Kane; S J Coker
Journal:  Br J Pharmacol       Date:  2007-10-29       Impact factor: 8.739

Review 9.  Minimizing repolarization-related proarrhythmic risk in drug development and clinical practice.

Authors:  Attila S Farkas; Stanley Nattel
Journal:  Drugs       Date:  2010-03-26       Impact factor: 9.546

Review 10.  The role of late I Na in development of cardiac arrhythmias.

Authors:  Charles Antzelevitch; Vladislav Nesterenko; John C Shryock; Sridharan Rajamani; Yejia Song; Luiz Belardinelli
Journal:  Handb Exp Pharmacol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.